The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: A pilot [11C]Ro15-4513 positron emission tomography study
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
GABA (gamma-amino-butyric-acid) is the primary inhibitory neurotransmitter in the human brain. It has been proposed that the symptoms of autism spectrum disorders (ASDs) are the result of deficient GABA neurotransmission, possibly including reduced expression of GABAA receptors. However, this hypothesis has not been directly tested in living adults with ASD. In this preliminary investigation, we used Positron Emission Tomography (PET) with the benzodiazepine receptor PET ligand [(11)C]Ro15-4513 to measure α1 and α5 subtypes of the GABAA receptor levels in the brain of three adult males with well-characterized high-functioning ASD compared with three healthy matched volunteers. We found significantly lower [(11)C]Ro15-4513 binding throughout the brain of participants with ASD (p < 0.0001) compared with controls. Planned region of interest analyses also revealed significant reductions in two limbic brain regions, namely the amygdala and nucleus accumbens bilaterally. Further analysis suggested that these results were driven by lower levels of the GABAA α5 subtype. These results provide initial evidence of a GABAA α5 deficit in ASD and support further investigations of the GABA system in this disorder. This article is part of the Special Issue entitled 'Neurodevelopmental Disorders'.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Strong association of de novo copy number mutations with autism
Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., et al. (2007) · Science · doi:10.1126/science.1138659 · Cited by 2,795
Model of autism: increased ratio of excitation/inhibition in key neural systems
Rubenstein, J. L. R., & Merzenich, M. M. (2003) · Genes, Brain and Behavior · doi:10.1034/j.1601-183x.2003.00037.x · Cited by 2,768 · cited 2×
“In particular, defects in GABA transmission, leading to brain hyperexcitability, have been hypothesized to underlie the symptoms of ASD (Pizzarelli and Cherubini, 2011; Rubenstein and Merzenich, 2003; Yizhar et al., 2011).”
Neocortical excitation/inhibition balance in information processing and social dysfunction
Yizhar, O., Fenno, L. E., Prigge, M., Schneider, F., Davidson, T. J., O’Shea, D. J., Sohal, V. S., Goshen, I., Finkelstein, J., Paz, J. T., et al. (2011) · Nature · doi:10.1038/nature10360 · Cited by 2,454 · cited 1×
“In particular, defects in GABA transmission, leading to brain hyperexcitability, have been hypothesized to underlie the symptoms of ASD (Pizzarelli and Cherubini, 2011; Rubenstein and Merzenich, 2003; Yizhar et al., 2011).”
Transcriptomic Analysis of Autistic Brain Reveals Convergent Molecular Pathology
Voineagu, I., Wang, X., Johnston, P., Lowe, J. K., Tian, Y., Horvath, S., Mill, J., Cantor, R. M., Blencowe, B. J., & Geschwind, D. H. (2011) · Nature · doi:10.1038/nature10110 · Cited by 1,874 · cited 1×
“Finally, reduced frontal and temporal cortical expression of mRNA in a network of genes highly expressed in GABA interneurons was observed in two samples of ASD (Voineagu et al., 2011).”
Amaral, D. G., Schumann, C. M., & Nordahl, C. W. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2007.12.005 · Cited by 1,492
Prevalence of autism-spectrum conditions: UK school-based population study
Baron-Cohen, S., Scott, F. J., Allison, C., Williams, J., Bolton, P., Matthews, F. E., & Brayne, C. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.059345 · Cited by 918
Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes
Rudolph, U., & Knoflach, F. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3502 · Cited by 733
Neuropathology of Infantile Autism
Kemper, T. L., & Bauman, M. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199807000-00001 · Cited by 585
McAlonan, G. M. (2004) · Brain · doi:10.1093/brain/awh332 · Cited by 491
King, B. H., Hollander, E., Sikich, L., McCracken, J. T., Scahill, L., Bregman, J. D., Donnelly, C. L., Anagnostou, E., Dukes, K., Sullivan, L., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.30 · Cited by 482
Scott‐Van Zeeland, A. A., Dapretto, M., Ghahremani, D. G., Poldrack, R. A., & Bookheimer, S. Y. (2010) · Autism Research · doi:10.1002/aur.122 · Cited by 458
GABAA Receptor Downregulation in Brains of Subjects with Autism
Fatemi, S. H., Reutiman, T. J., Folsom, T. D., & Thuras, P. D. (2009) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0646-7 · Cited by 439
Ecker, C., Marquand, A., Mourão-Miranda, J., Johnston, P., Daly, E. M., Brammer, M. J., Maltezos, S., Murphy, C. M., Robertson, D., Williams, S. C., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5413-09.2010 · Cited by 415 · cited 1×
“Numerous studies have reported differences in brain anatomy and function in individuals with ASD (e.g. see Craig et al., 2007; Ecker et al., 2010; Hallahan et al., 2009), but the underlying molecular basis of the condition remains unclear.”
Self-citationLinkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers
Cook, E. H., Courchesne, R. Y., Cox, N. J., Lord, C., Gonen, D., Guter, S. J., Lincoln, A., Nix, K., Haas, R., Leventhal, B. L., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301832 · Cited by 369 · cited 2×
“For instance, microduplications of the chromosome 15q11e13 locus have been observed in a proportion of people with ASD (Buxbaum et al., 2002; Cook et al., 1998; McCauley et al., 2004; Menold et al., 2001; Sebat et al., 2007; Shao et al., 2003).”
A Systematic Review of Medical Treatments for Children With Autism Spectrum Disorders
McPheeters, M. L., Warren, Z., Sathe, N., Bruzek, J. L., Krishnaswami, S., Jerome, R. N., & Veenstra-VanderWeele, J. (2011) · Pediatrics · doi:10.1542/peds.2011-0427 · Cited by 356 · cited 1×
“However, the efficacy of such pharmacotherapy has recently been questioned (McPheeters et al., 2011).”
Blatt, G. J., Fitzgerald, C. M., Guptill, J. T., Booker, A. B., Kemper, T. L., & Bauman, M. L. (2001) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1013238809666 · Cited by 322 · cited 3×
“Blatt and colleagues reported reduced GABAA receptors and benzodiazepine binding sites in the hippocampus (Blatt et al., 2001), and the cingulate cortex (Oblak et al., 2009, 2010) of individuals with ASD.”
Sedation and Anesthesia Mediated by Distinct GABA A Receptor Isoforms
Reynolds, D. S., Rosahl, T. W., Cirone, J., O'Meara, G. F., Haythornthwaite, A., Newman, R. J., Myers, J., Sur, C., Howell, O., Rutter, A. R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-24-08608.2003 · Cited by 318 · cited 1×
“The GABAA receptor family is the predominant type in the brain, and is the site of action of drugs such as benzodiazepines and several anaesthetics (Reynolds et al., 2003).”
Self-citationReward circuitry function in autism spectrum disorders
Dichter, G. S., Felder, J. N., Green, S. R., Rittenberg, A. M., Sasson, N. J., & Bodfish, J. W. (2012) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsq095 · Cited by 296
Ecker, C. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1251 · Cited by 259 · cited 2×
“However, the modest magnitude of the volumetric differences seen in most studies of high-functioning ASD (Ecker et al., 2012; McAlonan et al., 2005) suggests that it is unlikely that these could fully explain the present findings.”
Kubota, Y., Shigematsu, N., Karube, F., Sekigawa, A., Kato, S., Yamaguchi, N., Hirai, Y., Morishima, M., & Kawaguchi, Y. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhq252 · Cited by 235 · cited 2×
“Note that ADOS and IQ scores were only available for ASD individuals. is produced and released by inhibitory interneurons (Kubota et al., 2011; Tamamaki and Tomioka, 2010).”
Langen, M., Leemans, A., Johnston, P., Ecker, C., Daly, E., Murphy, C. M., dell’Acqua, F., Durston, S., & Murphy, D. G. M. (2012) · Cortex · doi:10.1016/j.cortex.2011.05.018 · Cited by 234 · cited 2×
“…anatomical developmental trajectories in the nucleus accumbens (Langen et al., 2009); impaired NAcc functional responses to social rewards (Scott-Van Zeeland et al., 2010); and abnormalities in white matter tracts connecting the frontal cortex to the nucleus accumbens (Langen et al., 2011).”
Self-citationLong-range GABAergic connections distributed throughout the neocortex and their possible function
Tamamaki, N., & Tomioka, R. (2010) · Frontiers in Neuroscience · doi:10.3389/fnins.2010.00202 · Cited by 116 · cited 2×
“Note that ADOS and IQ scores were only available for ASD individuals. is produced and released by inhibitory interneurons (Kubota et al., 2011; Tamamaki and Tomioka, 2010).”
Brain morphometry volume in autistic spectrum disorder: a magnetic resonance imaging study of adults
Hallahan, B., Daly, E. M., McAlonan, G., Loth, E., Toal, F., O'Brien, F., Robertson, D., Hales, S., Murphy, C., Murphy, K. C., et al. (2009) · Psychological Medicine · doi:10.1017/s0033291708003383 · Cited by 94 · cited 1×
“Numerous studies have reported differences in brain anatomy and function in individuals with ASD (e.g. see Craig et al., 2007; Ecker et al., 2010; Hallahan et al., 2009), but the underlying molecular basis of the condition remains unclear.”
Self-citation
Cited by
Ferguson, B. R., & Gao, W.-J. (2018) · Frontiers in Neural Circuits · doi:10.3389/fncir.2018.00037 · Cited by 594
GABA system dysfunction in autism and related disorders: From synapse to symptoms
Coghlan, S., Horder, J., Inkster, B., Mendez, M. A., Murphy, D. G., & Nutt, D. J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.07.005 · Cited by 446
Self-citationGABAA receptors: structure, function, pharmacology, and related disorders
Ghit, A., Assal, D., Al-Shami, A. S., & Hussein, D. E. E. (2021) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00224-0 · Cited by 405
Schür, R. R., Draisma, L. W. R., Wijnen, J. P., Boks, M. P., Koevoets, M. G. J. C., Joëls, M., Klomp, D. W., Kahn, R. S., & Vinkers, C. H. (2016) · Human Brain Mapping · doi:10.1002/hbm.23244 · Cited by 349
Howes, O. D., Rogdaki, M., Findon, J. L., Wichers, R. H., Charman, T., King, B. H., Loth, E., McAlonan, G. M., McCracken, J. T., Parr, J. R., et al. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117741766 · Cited by 342
“…support for the model comes from a positron-emission tomography (PET) study using a tracer that is relatively selective for the GABA-A alpha-5 receptor sub-type, showing elevated GABA receptor availability in ASD, potentially indicating reduced GABA transmitter levels (Mendez et al., 2013).”
Self-citation
Metadata
- Authors
- Mendez, M. A., Horder, J., Myers, J., Coghlan, S., Stokes, P., Erritzoe, D., Howes, O., Lingford-Hughes, A., Murphy, D., & Nutt, D.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 68
- Pages
- 195-201
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2040717681
- Cited by
- 126
- References
- 23
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.